Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum
Geoffrey D. Barnes, Allison Burnett, Arthur L. Allen, et al.
Journal of Thrombosis and Thrombolysis (2022) Vol. 54, Iss. 2, pp. 197-210
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

D-dimer: old dogmas, new (COVID-19) tricks
Giuseppe Lippi, François Mullier, Emmanuel J. Favaloro
Clinical Chemistry and Laboratory Medicine (CCLM) (2022) Vol. 61, Iss. 5, pp. 841-850
Open Access | Times Cited: 40
The intersection of obesity and (long) COVID-19: Hypoxia, thrombotic inflammation, and vascular endothelial injury
Mengqi Xiang, Xiaoming Wu, Haijiao Jing, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 38
Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization
Tracy Y. Wang, Abdus S. Wahed, Alison Morris, et al.
Annals of Internal Medicine (2023) Vol. 176, Iss. 4, pp. 515-523
Open Access | Times Cited: 28
Effectiveness of Drug Repurposing and Natural Products Against SARS-CoV-2: A Comprehensive Review
Paula Andrea Cuartas Velásquez, Juan C. Hernández, Elkin Galeano, et al.
Clinical Pharmacology Advances and Applications (2024) Vol. Volume 16, pp. 1-25
Open Access | Times Cited: 10
Appropriate thromboprophylaxis strategy for COVID-19 patients on dosage, antiplatelet therapy, outpatient and post-discharge prophylaxis: a meta-analysis of randomized controlled trials
Jiahao Meng, Hang Tang, Yifan Xiao, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 8
Rising consumption of anticoagulants in Central and Eastern European countries in the period 2007-2019
Kateřina Malá‐Ládová, Helena Šťastná Koblihová, Eva Zimčíková, et al.
Česká a slovenská farmacie (2025) Vol. 73, Iss. 4, pp. E1-E8
Closed Access
Beyond the Guidelines: Original Research on Real-World Outcomes of Anticoagulation and Corticosteroid in COVID-19
Alison Leslie, Scott A. Chapman, Katelyn M. Tessier, et al.
International Journal of Infectious Diseases (2025), pp. 107834-107834
Open Access
Thrombotic complications in children with Coronavirus disease 2019 and Multisystem Inflammatory Syndrome of Childhood
Riten Kumar, Michael J. Rivkin, Leslie Raffini
Journal of Thrombosis and Haemostasis (2023) Vol. 21, Iss. 9, pp. 2313-2326
Open Access | Times Cited: 13
D-dimer in diagnosis and prevention of venous thrombosis: recent advances and their practical implications
Benilde Cosmi, Cristina Legnani, Alessia Libra, et al.
Polskie Archiwum Medycyny Wewnętrznej (2023)
Open Access | Times Cited: 12
Anticoagulação Crônica em Pacientes com Fibrilação Atrial e COVID-19: Uma Revisão Sistemática e Metanálise
Isabela Landsteiner, Jonathan A. Pinheiro, Nicole Felix, et al.
Arquivos Brasileiros de Cardiologia (2024) Vol. 121, Iss. 3
Open Access | Times Cited: 3
Clinical decision support to enhance venous thromboembolism pharmacoprophylaxis prescribing for pediatric inpatients with COVID‐19
Adam Paul Yan, Chase Parsons, Gregory H. Caplan, et al.
Pediatric Blood & Cancer (2024) Vol. 71, Iss. 3
Closed Access | Times Cited: 2
Evaluating thromboprophylaxis in the sickle cell disease population: Navigating the evidence gap
Jennifer Davila, Sarah H. O’Brien, William B. Mitchell, et al.
British Journal of Haematology (2024) Vol. 204, Iss. 6, pp. 2184-2193
Closed Access | Times Cited: 2
Multidisciplinary Management Strategies for Long COVID: A Narrative Review
Christian Prusinski, Dan Yan, Johana Klasová, et al.
Cureus (2024)
Open Access | Times Cited: 2
Role of Therapeutic Anticoagulation in COVID-19: The Current Situation
Mandeep Singh Rahi, Jay Parekh, Prachi Pednekar, et al.
Hematology Reports (2023) Vol. 15, Iss. 2, pp. 358-369
Open Access | Times Cited: 6
Impact of Omicron variant infection on the liver, kidney, and coagulation system in patients undergoing elective surgery: a retrospective case-control study
Xiaojuan Xiong, Rui Li, Haoyu Pei, et al.
International Journal of Medical Sciences (2024) Vol. 21, Iss. 4, pp. 742-754
Open Access | Times Cited: 1
Venous Thromboembolism Management throughout the COVID-19 Era: Addressing Acute and Long-Term Challenges
Maddalena Alessandra Wu, Alba Taino, Pietro Facchinetti, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1825-1825
Open Access | Times Cited: 1
Thromboprophylaxis for Coagulopathy Related to COVID-19 in Pediatrics: A Narrative Review
Hadi Sahrai, Mahdi Hemmati-Ghavshough, Marzieh Shahrabi, et al.
Pediatric Drugs (2023) Vol. 25, Iss. 4, pp. 443-452
Open Access | Times Cited: 4
It’s in the blood: a review of the hematological system in SARS-CoV-2-associated COVID-19
James V. Harte, Caroline Coleman-Vaughan, Maeve P. Crowley, et al.
Critical Reviews in Clinical Laboratory Sciences (2023) Vol. 60, Iss. 8, pp. 595-624
Closed Access | Times Cited: 4
Evaluating research collaboration networks among venous thromboembolism researchers before and during the COVID-19 pandemic
Divya J. Karsanji, James A. King, Jenny Godley, et al.
Deleted Journal (2024) Vol. 1, Iss. 1, pp. 100004-100004
Open Access | Times Cited: 1
Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
Frauke Assmus, Jean‐Sélim Driouich, Rana Abdelnabi, et al.
Microorganisms (2022) Vol. 10, Iss. 8, pp. 1639-1639
Open Access | Times Cited: 6
Advancing anticoagulation stewardship: A call to action for stewardship from the US-based anticoagulation forum
Allison Burnett, Kelly Rudd, Darren M. Triller
Thrombosis Update (2022) Vol. 9, pp. 100125-100125
Open Access | Times Cited: 6
To prophylax or not, and how much and how long? Controversies in VTE prevention for medical inpatients, including COVID-19 inpatients
Alex C. Spyropoulos
Hematology (2022) Vol. 2022, Iss. 1, pp. 506-514
Open Access | Times Cited: 6
COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding
Pablo Demelo‐Rodríguez, Rubén Alonso-Beato, Luis Jara‐Palomares, et al.
Research and Practice in Thrombosis and Haemostasis (2023) Vol. 7, Iss. 7, pp. 102206-102206
Open Access | Times Cited: 3
COVID-19-associated Coagulopathy Characterization using Rotational Thromboelastometry in a Prospective, Observational Cohort Study: The HemoCoV Study
Anabela Rodrigues, Tiago Dias Domingues, Gustavo Nobre de Jesus, et al.
Acta Médica Portuguesa (2023) Vol. 36, Iss. 7-8, pp. 496-505
Open Access | Times Cited: 2
A systematic review on post-discharge venous thromboembolism prophylaxis in patients with COVID-19
Reza Amani‐Beni, Mohammad Kermani‐Alghoraishi, Bahar Darouei, et al.
The Egyptian Heart Journal (2023) Vol. 75, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top